Food and Drugs Administration reject use of Ampligen for people with chronic fatigue syndrome

December 7, 2009


The US Federal Food and Drugs Administration has refused to approve the use of the experimental drug Ampligen in patients with chronic fatigue syndrome. To read an account of the ruling and its effect on manufacturer Hemispherx BioPharma on TheStreet.com website, click here.

Shopping Cart